Compare F.N.B. Corporation Common Stock (FNB) vs Nutrien Ltd (NTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
F.N.B. Corporation Common Stock vs Nutrien Ltd — how do they compare? F.N.B. Corporation Common Stock trades at $16.96 (market cap $6.03B), while Nutrien Ltd trades at $69.87 (market cap $33.39B). The key difference: Nutrien Ltd is far larger — about 5.5× F.N.B. Corporation Common Stock's market cap, and Nutrien Ltd pays the higher dividend (3.15%). Which is the better fit depends on your goals — on Pluang, investors hold F.N.B. Corporation Common Stock for 0 Days and Nutrien Ltd for 60 Days on average.
| FNB | NTR | |
|---|---|---|
Market Cap | $6.03B | $33.39B |
Volume | 7,117,178 | 2,147,139 |
Sector | Financials | Basic Materials |
52-Week High | $19.49 | $83.94 |
52-Week Low | $14.65 | $53.64 |
Typical Hold Time | 0 Days | 60 Days |
Enterprise Value | $10.52B | $45.20B |
Dividend Yield | 3.07% | 3.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FNB trades at $17.05, down 0.76% on the day, with a neutral technical signal. The stock shows solid fundamentals with a P/E of 10.15 and P/B of 0.89, indicating potential undervaluation. Recent earnings have been mixed, with Q2 2026 beating estimates but Q1 missing. Revenue remains stable at $1.77 billion for 2025, with a strong net income margin of 33.04%. Analyst sentiment is positive, with 13 buy ratings and a consensus price target of $20.80.
The outlook for FNB is cautiously optimistic, supported by strong profitability and a favorable analyst consensus. Key opportunities include potential upside to the price target and consistent dividend payments. Risks involve earnings volatility, as seen in recent quarters, and competitive pressures in the banking sector. Investors should weigh the attractive valuation against execution risks and market conditions.
Nutrien (NTR) trades at $69.68, up 2.47% with mixed technical signals showing bearish momentum but oversold conditions. The company reported Q2 2026 earnings miss ($2.61 vs $2.70 expected) but maintains stable revenue growth projections. Strong institutional interest continues with BlackRock acquiring a $220 million position in Q2 2026, while analyst consensus remains positive with a $77.29 price target representing 11% upside potential.
The fertilizer producer faces near-term headwinds from potential Belarus potash imports but benefits from structural North American gas advantages. While technical indicators suggest caution, fundamental valuation metrics (P/E 14.11, P/S 1.19) appear reasonable given the company's market leadership position and improving profitability trends from 2024 lows.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About F.N.B. Corporation Common Stock
F.N.B. Corporation is a diversified financial services holding company headquartered in Pittsburgh, Pennsylvania, operating through its lead subsidiary, First National Bank of Pennsylvania. It provides commercial banking, consumer banking, wealth management, and insurance through more than 350 banking offices across seven states and Washington, D.C.
Read more on FNB →About Nutrien Ltd
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →
